12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

AnergiX: Phase I

Data from 31 patients showed that AnergiX.RA was safe and well tolerated at doses ranging from 0.5-150 ug/kg when given together with methotrexate, with no general immunosuppression or immunogenicity...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >